762
Views
10
CrossRef citations to date
0
Altmetric
Original Article: Research

Alcohol intake, alcoholic beverage type and multiple myeloma risk: a meta-analysis of 26 observational studies

, , , , &
Pages 1484-1501 | Received 22 May 2014, Accepted 13 Aug 2014, Published online: 20 Nov 2014
 

Abstract

This meta-analysis aimed to examine the association between alcohol consumption and multiple myeloma (MM) risk. Eligible publications were sought in PubMed to 31 December 2013. Separate analyses were performed by study design, gender, alcoholic beverages and levels of consumption. Sixteen case–control studies (3921 cases and 19 594 controls) and 10 cohort studies (3167 incident cases in total cohort of 2 557 649 subjects) were eligible. Ever consumption of alcohol was associated with reduced MM risk (pooled relative risk [RR] = 0.88, 95% confidence interval [CI]: 0.79–0.99) and especially consumption of wine correlated with reduced MM risk (pooled RR = 0.77, 95% CI: 0.67–0.89 for ever drinkers). MM risk was not affected by beer or liquor intake. A protective association was observed among females (pooled RR = 0.79, 95% CI: 0.69–0.89 for ever drinkers), whereas the association among males seemed null. In conclusion, contrary to most solid tumors, alcohol intake may confer protection in terms of MM risk among females, with wine being particularly beneficial.

Acknowledgements

The authors would like to thank the authors of individual studies who contributed their additional data and analyses, as detailed in the relevant section.

We are extremely thankful to and acknowledge the World Cancer Research Fund (WCRF), for the grant named “Identifying the role of nutrition, physical activity and body size in hematological malignancies through systematic reviews and meta-analyses” funded by Wereld Kanker Onderzoek Fonds (WCRF NL) and administered by WCRF International as part of the WCRF International program.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Supplementary material available online

Results, Tables and Figures showing further data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.